Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Nejman-Gryz (Warsaw, Poland), M. Paplinska-Goryca (Warsaw, Poland), M. Proboszcz (Warsaw, Poland), K. Górska (Warsaw, Poland), M. Maskey-Warzechowska (Warsaw, Poland), R. Krenke (Warsaw, Poland). The expression of selected biomarkers at the systemic and local level in patients with COPD. 4455

Member's Comments

No comment yet.

Related content which might interest you: Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Some local markers indices of saliva inflammation in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004 The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Cytokine regulation of local and systemic inflammation in COPD patients Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 The relationship between comorbidities and systemic inflammation in patients with COPD Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in patients with different severity of asthma and BHR level Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Different pattern of systemic and local inflammation in patients with exacerbation of COPD with different body composition Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Are there gender differences of systemic inflammatory state in COPD patients? Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 The increased production level of 15 cytokines associated with tuberculosis severity and patients’ responsiveness to therapy. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Serum TGF-β level in patients with different stages of stable COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008